Gene Therapy Market Research Reports & Industry Analysis

According to our (Global Info Research) latest study, the global GMP-grade AAV Vector Manufacturing Service market size was valued at US$ 890 million in 2025 and is forecast to a readjusted size of US...

The global GMP-grade AAV Vector Manufacturing Service market size is expected to reach $ 2085 million by 2032, rising at a market growth of 12.9% CAGR during the forecast period (2026-2032). GMP-grade...

According to our (Global Info Research) latest study, the global Research-grade AAV Vector Packaging Services market size was valued at US$ 272 million in 2025 and is forecast to a readjusted size of...

The global Research-grade AAV Vector Packaging Services market size is expected to reach $ 572 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032). Research...

According to our (Global Info Research) latest study, the global Single-stranded AAV Vector Packaging Service market size was valued at US$ 605 million in 2025 and is forecast to a readjusted size of...

The global Single-stranded AAV Vector Packaging Service market size is expected to reach $ 1584 million by 2032, rising at a market growth of 14.7% CAGR during the forecast period (2026-2032). Single-...

According to our (Global Info Research) latest study, the global ssAAV Vector Packaging Services market size was valued at US$ 605 million in 2025 and is forecast to a readjusted size of US$ 1584 mill...

The global ssAAV Vector Packaging Services market size is expected to reach $ 1584 million by 2032, rising at a market growth of 14.7% CAGR during the forecast period (2026-2032). ssAAV vector packagi...

The global Cell and Gene Therapy CRO market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. A Cell and Gene Therapy C...

The global Gene Therapy CRO Services market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gene therapy Contract Res...

The global AAV Vector-Based Gene Therapy Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV vector-base...

The global LV-Based Cell and Gene Therapy Products market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. LV-based ce...

The global Retrovirus-Based Gene Therapy Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Retrovirus-base...

The global Viral Vector-Based Gene Therapy Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Viral vector-...

HNY Research projects that the Gene Therapy market size will grow from 11629.24 Million USD in 2025 to 62674.31 Million USD by 2031, at an estimated CAGR of 32.41%. The base year considered for the st...

The global High Titer Lentiviral Packaging Systems market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. High titer...

The global Ocular Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Ocular...

The global Viral Vector Manufacturing Market size is forecast to increase from $9.02 Billion in 2026 to $30.61 Billion in 2034 at a CAGR of 16.5% between 2026 and 2034. The Viral Vector Manufacturing...

The global Oligonucleotide Therapeutics Market size is forecast to increase from $19.5 Billion in 2026 to $75.31 Billion in 2034 at a CAGR of 18.4% between 2026 and 2034. The Oligonucleotide Therapeut...

The global Lentiviral Vector Market size is forecast to increase from $1.91 Billion in 2026 to $4.84 Billion in 2034 at a CAGR of 12.33% between 2026 and 2034. The Lentiviral Vector market report prov...

The global Non-viral Gene Delivery Technologies Market size is forecast to increase from $4.89 Billion in 2026 to $12.89 Billion in 2034 at a CAGR of 12.88% between 2026 and 2034. The Non-viral Gene D...

The global Viral Vector Manufacturing for Gene Therapy market size is predicted to grow from US$ 814 million in 2025 to US$ 3661 million in 2032; it is expected to grow at a CAGR of 24.4% from 2026 to...

According to our (Global Info Research) latest study, the global Lentiviral Vector Production System market size was valued at US$ 1288 million in 2025 and is forecast to a readjusted size of US$ 2661...

The global Lentiviral Vector Production System market size is expected to reach $ 2661 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032). Lentiviral Vecto...

According to our (Global Info Research) latest study, the global Viral Vector Packaging Services market size was valued at US$ 1729 million in 2025 and is forecast to a readjusted size of US$ 3530 mil...

The global Viral Vector Packaging Services market size is expected to reach $ 3530 million by 2032, rising at a market growth of 10.6% CAGR during the forecast period (2026-2032). Viral Vector Packagi...

Gene Therapy For Rare Disease Marketis is growing with a CAGR of 26.50% during the forecast period 2026-2035. The Gene Therapy For Rare Disease Market emerges as a key focus in DataM Intelligence late...

Oligonucleotide Therapy Marketis is growing with a CAGR of 18.60% during the forecast period 2026-2035. The Oligonucleotide Therapy Market emerges as a key focus in DataM Intelligence latest in-depth...

Gene Therapies Marketis is growing with a CAGR of 23.10% during the forecast period 2026-2035. The Gene Therapies Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where se...

RNAi Technology Marketis is growing with a CAGR of 14.40% during the forecast period 2026-2035. The RNAi Technology Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...

According to our (Global Info Research) latest study, the global Telomere Gene Therapy market size was valued at US$ 22.64 million in 2025 and is forecast to a readjusted size of US$ 239 million by 20...

The global Telomere Gene Therapy market size is expected to reach $ 239 million by 2032, rising at a market growth of 37.1% CAGR during the forecast period (2026-2032). Telomere gene therapy is an ear...

Dystrophin Gene Therapy Market reached US$ 2.30 Billion in 2025 and is expected to reach US$ 12.00 Billion by 2033, growing with a CAGR of 20.60% during the forecast period 2026-2033. The Dystrophin G...

RNAi Therapeutics Marketis is growing with a CAGR of 14.60% during the forecast period 2026-2035. The RNAi Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...

According to our (Global Info Research) latest study, the global Gene Therapy Drug Delivery Tube market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 20...

The global Gene Interference Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Gene interference service...

Oligonucleotide Therapeutics Market The global oligonucleotide therapeutics market size was estimated at USD 7,200.00 million in 2025 and is projected to reach USD 29,608.38 million by 2033, growing a...

The global miRNA Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. miRNA inhibitor is a specially desi...

The global Small Interfering RNA (siRNA) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Small interfering RNA...

The Global Viral Vector and Plasmid DNA Manufacturing Market is projected to expand from USD 7.17 Billion in 2025 to USD 13.43 Billion by 2031, achieving an 11.03% CAGR. This sector specializes in pro...

The global AAV Vector Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV (Adeno-Associated Virus...

The global GMP Viral Vector Manufacturing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. GMP viral vector man...

The global Viral and Non Viral Vector Manufacturing market size is predicted to grow from US$ 1942 million in 2025 to US$ 4518 million in 2032; it is expected to grow at a CAGR of 13.1% from 2026 to 2...

The global Adeno-Associated Virus Gene Therapy market size is predicted to grow from US$ 1798 million in 2025 to US$ 3008 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032. U...

The global Gene Therapy for Neurodegenerative Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United...

The global AAV Vector CDMO Services market size is predicted to grow from US$ 172 million in 2025 to US$ 681 million in 2032; it is expected to grow at a CAGR of 22.2% from 2026 to 2032. AAV (Adeno-As...

The global Viral Vector CDMO Services market size is predicted to grow from US$ 814 million in 2025 to US$ 3661 million in 2032; it is expected to grow at a CAGR of 24.4% from 2026 to 2032. Viral Vect...

The global AAV Manufacturing Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV (Adeno-Associated Vir...

Antisense Oligonucleotides Market reached US$ 3,180.1 million in 2025 and is expected to reach US$ 5,286.96 million by 2033, growing with a CAGR of 6.50% during the forecast period 2026-2033. The Anti...

The global Gene Therapy in Cardiovascular Disorder market size is predicted to grow from US$ 593 million in 2025 to US$ 2317 million in 2032; it is expected to grow at a CAGR of 21.9% from 2026 to 203...